Richard A. Heyman

Insider Reports History

Entity
Individual
Location
5871 Oberlin Drive, Suite 150, San Diego, California
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Heyman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director Common Stock 130K $3.09M $23.70 Aug 15, 2024 Direct
Enliven Therapeutics, Inc. Director Common Stock 27.9K $662K $23.70 Aug 15, 2024 Indirect
RayzeBio, Inc. Director Common Stock 0 $0 $62.50 Feb 26, 2024 Direct
PMV Pharmaceuticals, Inc. Director Stock Option (right to buy) 67.5K Jun 6, 2024 Direct
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 29.2K Feb 13, 2024 Direct
Oric Pharmaceuticals, Inc. Director Stock Option (right to buy) 25.6K Jun 12, 2024 Direct
Gritstone bio, Inc. Director Stock Option (Right to Buy) 19K Jun 17, 2022 Direct
Metacrine, Inc. Director Stock Option (right to buy) 16.5K May 18, 2022 Direct
YUMANITY THERAPEUTICS, INC. Director Stock Option (Right to Buy) 14.8K Jun 2, 2021 Direct

Insider Reports Filed by Richard A. Heyman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELVN Enliven Therapeutics, Inc. Aug 15, 2024 2 -$29.5K 4 Aug 19, 2024 Director
ELVN Enliven Therapeutics, Inc. Jul 31, 2024 2 -$64.7K 4 Aug 2, 2024 Director
ELVN Enliven Therapeutics, Inc. Jul 15, 2024 1 -$31.5K 4 Jul 17, 2024 Director
ELVN Enliven Therapeutics, Inc. Jun 17, 2024 1 -$27.3K 4 Jun 20, 2024 Director
ORIC Oric Pharmaceuticals, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
PMVP PMV Pharmaceuticals, Inc. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director
ELVN Enliven Therapeutics, Inc. May 16, 2024 1 -$30.1K 4 May 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Apr 11, 2024 4 -$168K 4 Apr 15, 2024 Director
ELVN Enliven Therapeutics, Inc. Mar 19, 2024 1 -$18.4K 4 Mar 21, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 1 -$23M 4 Feb 27, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 15, 2024 1 -$22.1K 4 Feb 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
ELVN Enliven Therapeutics, Inc. Jan 30, 2024 1 -$20.8K 4 Feb 1, 2024 Director
ELVN Enliven Therapeutics, Inc. Dec 21, 2023 4 -$2.81K 4 Dec 26, 2023 Director
ELVN Enliven Therapeutics, Inc. Dec 19, 2023 3 -$55.7K 4 Dec 21, 2023 Director
RYZB RayzeBio, Inc. Sep 14, 2023 0 $0 3 Sep 14, 2023 Director
ORIC Oric Pharmaceuticals, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
PMVP PMV Pharmaceuticals, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 4 $0 4 Feb 27, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
GRTS Gritstone bio, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
ORIC Oric Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 17, 2022 Director
PMVP PMV Pharmaceuticals, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
MTCR Metacrine, Inc. May 18, 2022 1 $0 4 Sep 6, 2022 Director
ORIC Oric Pharmaceuticals, Inc. Sep 14, 2021 2 -$34.8K 4 Sep 16, 2021 Director
ORIC Oric Pharmaceuticals, Inc. Sep 10, 2021 2 -$27.1K 4 Sep 14, 2021 Director
ORIC Oric Pharmaceuticals, Inc. Sep 7, 2021 1 -$27.3K 4 Sep 9, 2021 Director
GRTS Gritstone bio, Inc. Jun 18, 2021 1 $0 4 Nov 19, 2021 Director
ORIC Oric Pharmaceuticals, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
PMVP PMV Pharmaceuticals, Inc. Jun 2, 2021 1 $0 4 Jun 9, 2021 Director
KA YUMANITY THERAPEUTICS, INC. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
PMVP PMV Pharmaceuticals, Inc. Jun 1, 2021 15 $832K 4 Jun 2, 2021 Director
MTCR Metacrine, Inc. May 24, 2021 1 $0 4 May 25, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 20, 2021 3 -$35.2K 4 May 24, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 14, 2021 3 -$149K 4 May 18, 2021 Director
PMVP PMV Pharmaceuticals, Inc. May 12, 2021 1 $0 4 Jul 23, 2021 Director
ORIC Oric Pharmaceuticals, Inc. May 11, 2021 1 -$2.51K 4 May 13, 2021 Director